Adaptimmune Therapeutics plc (ADAP) PT Lowered to $17 at Citi
Tweet
Share
E-mailGet Alerts ADAP Hot Sheet
Price: $0.05 --0%
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Citi lowered its price target on Adaptimmune Therapeutics plc (NASDAQ: ADAP) to $17.00 (from $18.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- Clearway Energy Inc. (CWEN) PT Lowered to $38 at Jefferies
- BRP Inc. (DOO:CN) (DOOO) PT Raised to Cdn$110 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
